Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA commissioner announcement possible before Congress adjourns, FDA's Schultz says.

Executive Summary

FDA COMMISSIONER ANNOUNCEMENT POSSIBLE BY END OF OCTOBER, Deputy Commissioner for Policy William Schultz predicted at a Food & Drug Law Institute meeting Sept. 3 in Washington, D.C. Asked to comment on the search for a new commissioner, Schultz responded: "Hopefully, there will be something announced relatively soon...before Congress goes out of session." The House and Senate both are expected to adjourn before Nov. 1. The Administration is not expected to present a nominee formally until after the FDA reform/Prescription Drug User Fee Act reauthorization bill is passed.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts